Bacterial Antigen Ingredients TRIZ Cases

Hyperimmune egg product treats dysbiosis by increasing beneficial flora and reducing intestinal permeability without side effects.

A hybrid peptide merges Protein G and Protein L domains to bind IgG Fc and Fab regions, overcoming weak Fab affinity in existing proteins.

A cell-penetrating conjugate delivers non-cell penetrating proteins into cells via a phosphorothioate nucleic acid backbone.

Sucrose and poloxamer prevent particle formation during dilution, maintaining Protein D stability.

SpoIVA and SpoVM assemble on lipid bilayers to create defined particle constructs, avoiding extraneous proteins that complicate biochemical analysis.

Zwitterionic polysaccharide PSA reduces central nervous system inflammation and increases survival rates in herpes simplex virus models.

High-pressure homogenization releases IgM protease antigen from E. coli into the supernatant, resolving yield versus purification trade-offs.

Co-expressing viral interferon suppressors in bacterial vectors overcomes host immune inhibition for robust antigen production.

Recombinant lipidated FLIPr overcomes low immunogenicity in subunit vaccines by inducing anti-FLIPr antibodies and activating complement components.

A recombinant rabies virus vector expresses filovirus glycoproteins to induce dual immune protection.

Outer membrane vesicles from Bordetella pertussis enhance antibody responses in combination vaccines.

Purified C. difficile toxoids A and B administered in a multi-dose regimen elicit sustained neutralizing antibodies, reducing infection recurrence rates.

Live attenuated Shigella flexneri strain expressing heterologous antigens to induce robust immune responses.

Modulating cell division genes to alter cyanobacterial morphology and improve harvestability.

Metabolic drift attenuation controls bacterial mutations to ensure vaccine stability and safety while simplifying production complexity.

Quadruple mutant Bordetella strain colonizes lungs and elicits protective immunity despite attenuated virulence.

Contiguous overlapping peptides derived from Der p 1 and Der p 2 allergens stimulate T-cell responses without forming native three-dimensional structures.

Combination therapy overcomes chronic inflammation and immunesuppression at tumour sites.

Nanoparticle vaccine compositions protect poultry from Salmonella colonization by preserving antigen stability during oral delivery.

Rapid reconstitution of frozen mutant diphtheria toxin in anhydrous dimethyl sulfoxide prevents beta-sheet mediated aggregation during conjugate formation.

Recombinant plasmid enables CTX phage replication in Vibrio cholerae strains, resolving biotype-specific constraints to increase cholera toxin yields.

Antibiotics remove undefined bacteria from Histomonas meleagridis cultures, creating single-strain vaccines that meet registration requirements.

Replacing thiomersal with a composite of 2-phenoxyethanol and benzyl alcohol prevents viral growth while eliminating mercury toxicity risks.

Segmented fusion proteins combined with BCG-CWS adjuvant overcome limited efficacy of current vaccines.

Extracting intact cell wall components improves assay sensitivity and specificity by eliminating interference from innate antibodies and non-specific binding.

Oil-water emulsions amplify MVA immunogenicity, achieving high antibody titers with reduced antigen quantities.

Recombinant Mycobacterium strains encode mutated LT toxin A subunits to stimulate targeted immune activation against tumor cells.

Segmented peptide formulations address variable BCG efficacy and drug-resistant strains by inducing robust opsonization and long-term immunity.

OmpAtb antigen detects cell-mediated immune responses for tuberculosis diagnosis.

A bivalent vaccine formulation combines inactivated Aliivibrio wodanis and Moritella viscosa bacteria to deliver broad-spectrum protection against fish pathogens.

Merges inactivated and live attenuated antigens with an oil adjuvant to resolve vaccination complexity while maintaining safety across PRRS-negative animals.

Merges glycolipid-CD1d complexes with TAA/ecdCD40L to resolve the contradiction between vaccine versatility and robust immune response magnitude.

A cationic adjuvant composition combines DDA, MMG, and CpG ODN 2006 to stimulate both humoral and cellular immunity.

A MAPS vaccine polymer scaffold links multiple antigens to elicit robust humoral and cellular immune responses.

A chimeric antigen vaccine induces protective immunity against cattle tick infestations.

Recombinant mycobacteria mutants lacking nlaA and nuoG genes induce host cell apoptosis to enhance vaccine efficacy.

Small-molecule inhibitors coordinate zinc ions in the active site to block enzymatic activity.

Live oral vaccine uses attenuated EHEC to deliver C. difficile toxin antigens, overcoming antibiotic resistance and high recurrence rates.

Whole genome sequencing identifies novel capsular loci to formulate targeted Streptococcus suis vaccines against reproductive and nursery-age diseases.

Chemically modified MTB antigens stimulate robust cellular and humoral immune responses through targeted antibody production.

Detoxified tetanus neurotoxin carries SARS-CoV-2 epitopes to memory cells, preventing cytokine storms.

Enriched PSII polysaccharide combined with carrier protein elicits specific antibodies to reduce C. difficile recurrence.

Maize grain expresses Borrelia burgdorferi OspA antigen to overcome digestive degradation and reduce production costs.

Antibodies detect Campylobacter jejuni toxins to diagnose irritable bowel syndrome while neutralizing harmful effects through specific binding.

A combination vaccine formulation delivers Mycoplasma hyopneumoniae and PCV2 antigens via intradermal injection.

Segmented MTB peptides target multiple immune responses to distinguish active from latent infections.

A recombinant spiralin protein enables serological detection of transmissible spongiform encephalopathies through specific antibody-antigen immune reactions.